ARTICLE | Politics & Policy

ASCO, Friends of Cancer outline more inclusive cancer trials

October 2, 2017 10:25 PM UTC

The American Society of Clinical Oncology and Friends of Cancer Research published recommendations on how to achieve more inclusive enrollment in cancer clinical trials.

The recommendations, published in the Journal of Clinical Oncology (JCO), are in line with those first unveiled at the ASCO annual meeting and discussed at a stakeholders' meeting with FDA in June. They outline five key areas where eligibility criteria can be broadened to expand enrollment to groups that are usually excluded from cancer trials, including patients with brain metastases, HIV-infected patients, children aged 12 and older, patients with current or prior malignancies, and those with organ damage (see BioCentury, June 9)...